Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV-Reference-Cited by-同舟云学术

Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV

Published:2020-12 Issue: Volume:19 Page:78-88
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Powell Allison B.,Ren Yanqin,Korom Maria,Saunders Devin,Hanley Patrick J.,Goldstein Harris,Nixon Douglas F.,Bollard Catherine M.,Lynch Rebecca M.,Jones R. Brad,Cruz Conrad Russell Y.

Funder

National Institute of Allergy and Infectious Disease

Martin Delaney Collaboratory

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference55 articles.

1. HIV;Ghosn;Lancet,2018

2. Hematopoietic stem cell transplantation for HIV cure;Kuritzkes;J. Clin. Invest.,2016

3. T-cell therapies for HIV: Preclinical successes and current clinical strategies;Patel;Cytotherapy,2016

4. Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection;Cohen;Curr. Opin. HIV AIDS,2018

5. Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point;Ndhlovu;Immunity,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CBP/p300 lysine acetyltransferases inhibit HIV-1 expression in latently infected T-cells;2024-07-06

2. Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study;Cell Discovery;2024-05-14

3. Small molecule inhibitors of transcriptional cyclin-dependent kinases impose HIV-1 latency, presenting “block and lock” treatment strategies;Antimicrobial Agents and Chemotherapy;2024-03-06

4. Photothermal Prussian blue nanoparticles generate potent multi‐targeted tumor‐specific T cells as an adoptive cell therapy;Bioengineering & Translational Medicine;2023-12-22

5. Broadly neutralizing antibodies targeting HIV: Progress and challenges;Clinical Immunology;2023-12